TY  - RPRT
TI  - Clinical Trial: Phase 3 Trial of Resmetirom Versus Placebo in Metabolic Dysfunction-Associated Steatohepatitis-Reanalysis of Fibrosis Stage 2-3 Subset.
AU  - Maria Mironova
AU  - Krishna Padmanabhan
AU  - David Schneider
AU  - Jörn M Schattenberg
AU  - Rohit Loomba
PY  - 2026
DO  - 10.1111/apt.70888
UR  - https://pubmed.ncbi.nlm.nih.gov/42527732/
ID  - 42527732
ER  -